MPH Health Care AG (93M1) - Total Liabilities

Latest as of December 2025: €14.68 Million EUR ≈ $17.16 Million USD

Based on the latest financial reports, MPH Health Care AG (93M1) has total liabilities worth €14.68 Million EUR (≈ $17.16 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of MPH Health Care AG to evaluate the company's liquid asset resilience ratio.

MPH Health Care AG - Total Liabilities Trend (2016–2025)

This chart illustrates how MPH Health Care AG's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see how large is MPH Health Care AG's balance sheet.

MPH Health Care AG Competitors by Total Liabilities

The table below lists competitors of MPH Health Care AG ranked by their total liabilities.

Company Country Total Liabilities
Trigg Minerals Ltd
AU:TMG
Australia AU$536.08K
E-Data Teknoloji Pazarlama AS
IS:EDATA
Turkey TL301.17 Million
Severn Trent PLC
LSE:SVT
UK GBX15.73 Billion
Team Precision Public Company Limited
BK:TEAM
Thailand ฿767.61 Million
FastPartner AB Series D
ST:FPAR-D
Sweden Skr21.73 Billion
AnaPass Inc
KQ:123860
Korea ₩51.75 Billion
Global Fashion Group S.A
F:GFG
Germany €353.40 Million
Tesoro Gold Ltd
AU:TSO
Australia AU$1.85 Million

Liability Composition Analysis (2016–2025)

This chart breaks down MPH Health Care AG's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See MPH Health Care AG (93M1) net asset quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 0.16 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.06 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.06 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how MPH Health Care AG's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for MPH Health Care AG (2016–2025)

The table below shows the annual total liabilities of MPH Health Care AG from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 €14.68 Million
≈ $17.16 Million
+11.28%
2024-12-31 €13.19 Million
≈ $15.42 Million
-14.26%
2023-12-31 €15.39 Million
≈ $17.99 Million
-1.18%
2022-12-31 €15.57 Million
≈ $18.20 Million
+173.66%
2021-12-31 €5.69 Million
≈ $6.65 Million
-39.76%
2020-12-31 €9.45 Million
≈ $11.04 Million
-56.07%
2019-12-31 €21.50 Million
≈ $25.14 Million
+25.57%
2018-12-31 €17.13 Million
≈ $20.02 Million
+2.47%
2017-12-31 €16.71 Million
≈ $19.54 Million
+2.01%
2016-12-31 €16.38 Million
≈ $19.15 Million
--

About MPH Health Care AG

F:93M1 Germany Asset Management
Market Cap
$132.14 Million
€113.03 Million EUR
Market Cap Rank
#18861 Global
#1734 in Germany
Share Price
€26.40
Change (1 day)
-2.22%
52-Week Range
€17.25 - €29.70
All Time High
€47.41
About

MPH Health Care AG, an investment company, engages in the healthcare business in Germany. It operates through Beauty, Pharma, and Real Estate segments. The company offers medical-aesthetic beauty surgeries and treatments, as well as operation and provision of medical infrastructures for partner companies; and sells pharmaceuticals and medical products in the areas of oncology, HIV/AIDS, neurology… Read more